ACHV: Achieve Life Sciences, Inc.
Performance
ACHV +47.71%
Watchlist
Select an item
Summary
ACHV at a glance
ACHV returned +47.71% over the past year and -4.68% a year over five years. Its worst drop in that year was -54.55%, smaller than 17% of stocks on Redstone, and its Sharpe ratio of 0.84 beats 68% of stocks on Redstone. It pays no dividends.
Current Drawdown
-20.52%
Rolling Volatility
62.63%
Actions
Metrics
Risk Indicators
Alpha49.83%
Beta1.84x
Sharpe0.84
Sortino1.27
Omega1.17
Calmar0.87
Martin3.50
Profile
About ACHV
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence.
- Sector
- Health Care
- Industry
- In Vitro & in Vivo Diagnostic Substances
- Market cap
- $699M
- Listed
- Oct 1995
- Employees
- 28
- Headquarters
- Seattle, WA
- Website
- achievelifesciences.com
Comparisons